BIO Elects New Officers, Welcomes 10 New Board Members

  • Contact: Ellen Dadisman
  • Phone: 202-312-9299
  • Recommend
  • Tweet
  • Print
  • Email

ATLANTA, GA (May 18, 2009) – The Board of Directors of the Biotechnology Industry Organization today elected a new slate of officers and 10 new board members at its meeting at BIO’s 2009 Annual Convention. 

“We are honored to have some of the industry’s best thinkers working closely with our membership and senior staff,” said BIO President and CEO Jim Greenwood.  “Each of these individuals brings exceptional perspective, insight, and experience that will contribute to the health and growth of the industry, as well as the judicious oversight of BIO as a membership organization.”

The members of the Executive Committee of BIO’s Board of Directors are:

Stephen A. Sherwin, MD, Board Chair*
            CEO, Cell Genesys, Inc.

Mark Skaletsky, Treasurer*
            President & CEO, Fenway Pharmaceuticals

Fabrizio Bonanni, Secretary*
            EVP, Operations, Amgen

Joshua Boger, PhD, Immediate Past Chair
            CEO, Vertex Pharmaceuticals, Inc.

Rachel King, Chair for Emerging Companies*
            CEO, Glycomimetics

Ron Cohen, Vice Chair for Emerging Companies
            President & CEO, Acorda Therapeutics

Joachim Schneider, Chair for the Food & Ag Section*
            Head of BioScience, Bayer CropScience

Barbara Wells, PhD, Vice Chair for the Food & Ag Section

President & CEO, ArborGen, LLC

 

Tom Watkins, Vice Chair for the Health Section*

            CEO, Human Genome Sciences

 

Alan Shaw, Chair for the Industrial & Environmental Section*

            CEO, Codexis

 

Tjerk de Ruiter, Vice Chair for the Industrial & Environmental Section

            CEO, Genencor

 

Ian T. Clark, At Large

            Head of Global Product Strategy & Chief Marketing Officer, Roche Pharma Division

 

Douglas A. Doerfler, At Large

            President & CEO, Maxcyte, Inc.

 

Paul Hastings, At Large

            President & CEO, Oncomed Pharmaceuticals, Inc.

 

James C. Mullen, At Large

            President & CEO, Biogen Idec, Inc.

 

Richard F. Pops, At Large

            Chairman, Alkermes, Inc.

 

David E. I. Pyott, At Large

            Chairman & CEO, Allergan

           

Henri A. Termeer, At Large

            Chairman, President & CEO, Genzyme Corporation.

 

*also serves as an Officer of the Board of Directors

 

BIO’s Board of Directors is composed of members of the Governing Boards for each of BIO’s four sections:  Health, Emerging Companies, Industrial & Environmental and Food & Agriculture.  The new members of BIO’s Board of Directors are:

 

Ian T. Clark, Head of Global Product Strategy & Chief Marketing Officer, Roche Pharma Division

            (also of BIO’s Health Governing Board)

 

Peter Eckes, CEO & Managing Director, BASF Plant Science

(also of BIO’s Food & Agriculture Governing Board)

 

Sue Ellerbusch, President, BP Biofuels North America

(also of BIO’s Industrial & Environmental Governing Board)

 

Stephen J. Gatto, Chairman & CEO, Bioenergy International, LLC

(also of BIO’s Industrial & Environmental Governing Board)

 

Perry Karsen, Chief Executive Officer, Pearl Therapeutics

(also of BIO’s Emerging Companies Governing Board)

 

Daphne Preuss, Chief Executive Officer, Chromatin, Inc.

(also of BIO’s Food & Agriculture Governing Board)

 

Arthur Sands, MD, PhD, President & CEO, Lexicon Genetics Incorporated

(also of BIO’s Emerging Companies Governing Board)

 

Ron Stotish, Chief Executive Officer, Aqua Bounty Technologies

(also of BIO’s Food & Agriculture Governing Board)

 

Ellen Strahlman, MD, Senior Vice President & Chief Medical Officer, GlaxoSmithKline, PLC

(also of BIO’s Health Section Governing Board)

 

Mark Wong, Chief Executive Officer, Agrivida

(also of BIO’s Food & Agriculture Governing Board)

 

# # #

Upcoming BIO Events

BioEquity Europe
June 9-10, 2009
Munich, Germany

World Congress on Industrial Biotechnology & Bioprocessing
July 19-22, 2009
Montreal, Quebec, Canada

 

About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

###

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.